COLL vs. CPRX
Compare and contrast key facts about Collegium Pharmaceutical, Inc. (COLL) and Catalyst Pharmaceuticals, Inc. (CPRX).
Performance
COLL vs. CPRX - Performance Comparison
Loading graphics...
COLL vs. CPRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
COLL Collegium Pharmaceutical, Inc. | -28.57% | 61.61% | -6.92% | 32.67% | 24.20% | -6.74% | -2.67% | 19.86% | -6.99% | 18.56% |
CPRX Catalyst Pharmaceuticals, Inc. | 6.08% | 11.84% | 24.15% | -9.62% | 174.74% | 102.69% | -10.93% | 95.31% | -50.90% | 272.38% |
Fundamentals
COLL:
$1.31B
CPRX:
$3.15B
COLL:
$1.60
CPRX:
$1.68
COLL:
20.73
CPRX:
14.71
COLL:
0.50
CPRX:
0.26
COLL:
1.67
CPRX:
5.35
COLL:
4.35
CPRX:
3.30
COLL:
$780.57M
CPRX:
$588.99M
COLL:
$463.26M
CPRX:
$726.82M
COLL:
$599.85M
CPRX:
$257.78M
Returns By Period
In the year-to-date period, COLL achieves a -28.57% return, which is significantly lower than CPRX's 6.08% return. Over the past 10 years, COLL has underperformed CPRX with an annualized return of 5.60%, while CPRX has yielded a comparatively higher 35.35% annualized return.
COLL
- 1D
- 3.38%
- 1M
- -20.64%
- YTD
- -28.57%
- 6M
- -5.49%
- 1Y
- 10.79%
- 3Y*
- 11.29%
- 5Y*
- 7.18%
- 10Y*
- 5.60%
CPRX
- 1D
- 4.12%
- 1M
- 7.28%
- YTD
- 6.08%
- 6M
- 25.69%
- 1Y
- 2.10%
- 3Y*
- 14.30%
- 5Y*
- 40.58%
- 10Y*
- 35.35%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
COLL vs. CPRX — Risk / Return Rank
COLL
CPRX
COLL vs. CPRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Collegium Pharmaceutical, Inc. (COLL) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| COLL | CPRX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.28 | 0.06 | +0.22 |
Sortino ratioReturn per unit of downside risk | 0.70 | 0.32 | +0.38 |
Omega ratioGain probability vs. loss probability | 1.08 | 1.04 | +0.04 |
Calmar ratioReturn relative to maximum drawdown | 0.32 | 0.01 | +0.31 |
Martin ratioReturn relative to average drawdown | 1.02 | 0.02 | +1.00 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| COLL | CPRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.28 | 0.06 | +0.22 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.18 | 0.85 | -0.67 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.10 | 0.56 | -0.46 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.16 | 0.08 | +0.09 |
Correlation
The correlation between COLL and CPRX is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
COLL vs. CPRX - Dividend Comparison
Neither COLL nor CPRX has paid dividends to shareholders.
Drawdowns
COLL vs. CPRX - Drawdown Comparison
The maximum COLL drawdown since its inception was -73.59%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for COLL and CPRX.
Loading graphics...
Drawdown Indicators
| COLL | CPRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -73.59% | -94.25% | +20.66% |
Max Drawdown (1Y)Largest decline over 1 year | -35.81% | -27.29% | -8.52% |
Max Drawdown (5Y)Largest decline over 5 years | -43.99% | -45.37% | +1.38% |
Max Drawdown (10Y)Largest decline over 10 years | -65.22% | -64.87% | -0.35% |
Current DrawdownCurrent decline from peak | -33.65% | -5.89% | -27.76% |
Average DrawdownAverage peak-to-trough decline | -31.16% | -52.51% | +21.35% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.09% | 15.10% | -4.01% |
Volatility
COLL vs. CPRX - Volatility Comparison
Collegium Pharmaceutical, Inc. (COLL) has a higher volatility of 11.70% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 10.39%. This indicates that COLL's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| COLL | CPRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.70% | 10.39% | +1.31% |
Volatility (6M)Calculated over the trailing 6-month period | 27.82% | 23.71% | +4.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 39.31% | 34.96% | +4.35% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.24% | 48.24% | -8.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 54.39% | 62.81% | -8.42% |
Financials
COLL vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between Collegium Pharmaceutical, Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities